The Latest
-
Ascension to buy Tennessee system Williamson Health in $1B deal
Ascension beat out other offers, including from HCA and Optum, to give Williamson a financial lifeline amid serious challenges facing regional hospital operators. The deal is expected to be final by 2028 at the latest.
-
Sponsored by RAAPID INC
KLAS Emerging Company Spotlight: Enhancing risk adjustment coding defensibility through neuro-symbolic AI solutions
See the grades RAAPID's customers gave in the 2026 KLAS Emerging Company Spotlight.
-
Epic president to step down this summer
Sumit Rana’s departure could be a significant leadership shakeup for Epic, as the president was viewed as a potential successor to the EHR vendor’s 82-year-old CEO.
Updated July 8, 2026 -
AdaptHealth discloses patient data was stolen in cyberattack
The medical device supplier said that a threat actor accessed company systems through a social engineering attack.
-
Private equity may skirt oversight with nonprofit healthcare joint ventures
The investment firms are leaning on joint ventures with nonprofits to expand in the healthcare sector, according to a new report from the Private Equity Stakeholder Project.
-
Opinion
Healthcare faces congressional oversight heading into 2026 midterms and beyond
Democrats are planning investigations into major healthcare topics if they win majorities in Congress this November. Healthcare firms should prepare for increased oversight now, write lawyers with Holland & Knight.
-
Elevance sues CMS after Medicare Advantage stars recalculation
Regulators recalculated plans’ quality scores last month after losing a lawsuit to Clover Health. But they used a different methodology for Clover than its peers, causing Elevance to lose out on $115 million, the insurer told a court.
-
Medtronic starts to notify people affected by cyberattack
The medtech giant said it currently has no evidence that the accessed data has been posted to the internet.
-
Medicare slashes 340B payments, broadens site-neutral policies in proposed 2027 payment rule
The rule, released Thursday, builds on Trump administration’s priorities, including cutting Medicare reimbursement for drugs in the controversial 340B program and equalizing payment between sites of care.
-
Medicare Advantage bonuses will exceed $13B this year, KFF finds
Medicare is spending more on quality bonuses despite fewer enrollees in eligible plans, the health policy research group said — a concerning trend putting more stress on Medicare’s coffers that could amplify calls for reform.
-
Allegheny Health Network, Heritage Valley finalize combination in Pennsylvania
The deal brings Highmark Health-owned AHN’s hospital count to 16. The combined system will invest about $285 million over the next decade to bolster Heritage Valley’s facilities.
-
Court dismisses PBMs’ lawsuit against FTC following insulin settlements
Express Scripts, Caremark and Optum Rx sued the FTC after the agency accused them of driving up the cost of insulin. But the countersuit is being put to bed now that the PBMs are settling with regulators.
-
Fewer health information exchanges say they experience info blocking
Fewer companies appear to be impeding the flow of digital health information, but some could be doing so frequently, the ONC said.
-
AHA taps state advocate as new CEO
Steve Walsh, the CEO of a Massachusetts hospital group, will assume the top role in the early fall, after the AHA’s longtime leader Rick Pollack retires.
-
Nearly 4M Medicare beneficiaries could access GLP-1s for weight loss under new program: analysis
Millions of people could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a report by KFF.
-
States sue Trump administration over Medicaid work requirements rule
Twenty-six states are seeking to overturn some of the regulation released by the CMS this month that outlined Medicaid work requirements — and asking the court to pause implementation for the time being.
-
Top FDA gene and cell therapy regulator to step down
Following Vijay Kumar’s exit, acting CBER Director Karim Mikhail will also oversee a review office that has become a battleground for debates on FDA flexibility.
-
ACA enrollment declines by nearly 3M
ACA plan enrollment continues to shrink following the lapse of more generous subsidies last year, according to new federal data.
-
ONC rolls out new TEFCA oversight efforts
The health IT regulator awarded a new contract to oversee the framework’s rules for data sharing as the number of health records exchanged through TEFCA balloons.
-
Top healthcare conferences to attend in 2026
These are the events healthcare leaders should plan for this year, covering topics like digital health, rural care and financial management.
Updated June 29, 2026 -
Rush health system CEO to step down in 2027
The system said a longer transition before Dr. Omar Lateef’s departure will ensure stability as it searches for a new leader.
-
State Medicaid directors defend program integrity as Dems cry foul in House hearing
The Trump administration says its war on fraud applies to the entire country. But only blue states have had their Medicaid funding threatened or deferred, Democrats argued in a House subcommittee hearing Thursday.
-
Aidoc wins breakthrough nod for AI that reads chest X-rays
Aidoc is working on an artificial intelligence feature that would analyze chest X-rays and generate preliminary reports for more than 100 findings.
-
HHS details takeaways from sweeping AI request for information
The healthcare sector wants the HHS to coordinate its AI strategy across agencies, provide implementation and governance support, and offer help in evaluating AI tools, leaders said.
-
US health spending spikes to $5.7T in 2025, though growth should moderate, CMS finds
Utilization — not cost growth — continues to accelerate spending, government actuaries said. Rising prescription drug spending, including on GLP-1s, is especially acute.
-
Patient messages to providers have skyrocketed, study finds
Between 2020 and 2025, patient-written messages increased 153%, according to the study in JAMA. But office visits also rose, suggesting messaging doesn’t replace in-person care.